J Endocrinol 243(2):149160 Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM et al (2020) Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
Phase 2 used more aggressive titration
Early studies suggest retatrutide can deliver dramatic weight loss and preserve muscle
Limit Refined Sugars and Carbs Highly processed foods that spike blood sugar can undermine GLP-1's natural role
Practical Timing Strategies and Side Effect Management To minimize nauseathe most common early side effectmany patients find that injecting on a day when they can eat light, frequent meals works better than days preceding heavy social eating events
Older Ozempic lawsuit and settlement updates September 2023: On September 22, 2023, the FDA approved a drug label change indicating that Ozempic has the potential to lead to gastrointestinal disorders including Ileus (a non-mechanical bowel obstruction)